Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations-Reference-Cited by-同舟云学术

Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations

Published:2022-09 Issue: Volume:23 Page:101471
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Canale Matteo^ORCID,Petracci Elisabetta,Cravero Paola,Mariotti Marita,Minuti Gabriele,Metro Giulio,Ludovini Vienna,Baglivo Sara^ORCID,Puccetti Maurizio,Dubini Alessandra,Martinelli Giovanni,Delmonte Angelo,Crinò Lucio,Ulivi Paola^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference57 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA. Cancer J. Clin.,2021

2. Role and targeting of anaplastic lymphoma kinase in cancer;Della Corte;Mol. Cancer,2018

3. Hunting ALK to feed targeted cancer therapy;Wellstein;Nat. Med.,2011

4. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

5. Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer;Wu;Cancers (Basel),2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors;MedComm;2024-06

2. Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC;Cancer Research Communications;2024-03-14

3. Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC;Journal of Thoracic Oncology;2024-01

4. Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR, ALK and ROS1 tyrosine kinase inhibitors: An update;Tumor Biology;2023-10-12

5. Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non–Small Cell Lung Cancer;Clinical Medicine Insights: Oncology;2023-01